Pharmaceutical
Home » Human Chorionic Gonadotropin Market

Human Chorionic Gonadotropin Market

Human Chorionic Gonadotropin Market By Treatment (Female Infertility Treatment, Oligospermia Treatment, Cryptorchidism Treatment), By Technology (Natural Source Extraction, Recombinant Dna Technology) – Growth, Share, Opportunities & Competitive Analysis, 2016 – 2022
Report Book

Published Date: Jul. 2016
Category: Pharmaceuticals
Report ID: 57982
Report Format: PDF
No of Pages: 190

Rating: Credence Reports

Market Insights

Fertility patterns worldwide have changed dramatically and a rise in the infertility rates have been observed since the last two decades. Even though newer assisted techniques such as in-vitro fertilization have been well developed, still fertility drugs are the first choice for treatment of infertility issues. Even in the fertility drugs category, hormonal products are preferred the most. Since the human body is governed by hormones, infertility is considered to be caused due to the abnormal play of the hormones.

This report studies the global human chorionic gonadotropin (HCG) market based on use of human chorionic gonadotropin in various treatments and production technologies. HCG is widely used for female infertility treatment, oligospermia, and cryptorchidism treatments. Based on manufacturing technologies the HCG market is categorized into natural source extraction and recombinant DNA technology. This report studies these segments in terms of their historical and future market size and forecast for the period 2014-2022. Respective compounded annual growth rates (CAGR %) for these segments for the period 2016-2022 are also presented in this study.

Geographically, the global human chorionic gonadotropin market is studied for the following regional markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Rest of Asia-Pacific
  • Middle East and Africa
  • Latin America

The market size and forecast for the period 2014-2022 along with the CAGRs for the period 2016-2022 are also provided in this report.

Qualitative information such as drivers, restraints and future opportunities for the global hospital-acquired disease testing market are included in this report. Competition assessment tools such as competition analysis and attractive investment proposition are presented in this study for scrutinizing competition of the global human chorionic gonadotropin market. This study concludes with the company profiles section that highlights information about the key companies engaged in development, manufacture and provision of human chorionic gonadotropin products.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Human Chorionic Gonadotropin Market, by Therapeutic Area, 2015 (USD Mn)
2.2 Global Human Chorionic Gonadotropin Market, by Technology, 2015 (USD Mn)
2.3 Global Human Chorionic Gonadotropin Market, by Therapeutic Area Market, by Geography, 2015 (Value %)

Chapter 3 Global Hematopoietic Stem Cells Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 High Infertility Prevalence Worldwide
3.3 Market Restraints
3.3.1 Availability of Substitutes
3.4 Market Opportunities
3.4.1 Demand for Recombinant HCG
3.5 Attractive Investment Proposition
3.6 Market Competition Assessment: Human Chorionic Gonadotropin Market, by Key Players

Chapter 4 Global Human Chorionic Gonadotropin Market Analysis, By Treatment
4.1 Overview
4.2 Female Infertility Treatment
4.3 Oligospermia Treatment
4.4 Cryptorchidism Treatment
4.5 Others

Chapter 5 Global Human Chorionic Gonadotropin Market Analysis, By Technology
5.1 Overview
5.2 Natural Source Extraction
5.3 Recombinant DNA Technology

Chapter 6 Global Human Chorionic Gonadotropin Market, By Geography
6.1 Preface
6.2 North America
6.3 Europe
6.4 Asia-Pacific
6.5 Latin America
6.6 Middle East and Africa

Chapter 7 Company Profiles
7.1 Ferring B.V.
7.1.1 Ferring B.V.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.3 EMD Serono, Inc.
7.3.1 EMD Serono, Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.4 Fresenius Kabi USA, LLC
7.4.1 Fresenius Kabi USA, LLC: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.5 Merck & Co., Inc.
7.5.1 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)

List of Figures

FIG. 1 Human Chorionic Gonadotropin Market: Research Methodology
FIG. 2 Global Human Chorionic Gonadotropin Market, by Therapeutic Area, 2015 (USD Mn)
FIG. 3 Global Human Chorionic Gonadotropin Market, by Technology, 2015 v/s 2022 (Value %)
FIG. 4 Global Human Chorionic Gonadotropin Market, by Geography, 2015 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography, 2015
FIG. 6 HCG Market in Female Infertility Treatment, 2014 – 2022 (USD Mn)
FIG. 7 HCG Market in Oligospermia Treatment, 2014 – 2022 (USD Mn)
FIG. 8 HCG Market in Cryptorchidism Treatment, 2014 – 2022 (USD Mn)
FIG. 9 HCG Market in Other Treatments, 2014 – 2022 (USD Mn)
FIG. 10 HCG from Natural Source Extraction Market, 2014 – 2022 (USD Mn)
FIG. 11 HCG from Recombinant DNA Technology Market, 2014 – 2022 (USD Mn)
FIG. 12 North America Human Chorionic Gonadotropin Market, By Country, 2013 – 2022 (USD Mn)
FIG. 13 Europe Hematopoietic Stem Cell Transplant Market , 2013 – 2022 (USD Mn)
FIG. 14 Asia-Pacific Human Chorionic Gonadotropin Market , 2013 – 2022 (USD Mn)
FIG. 15 Latin America Human Chorionic Gonadotropin Market, 2016 – 2022 (USD Mn)
FIG. 16 Middle East and Africa Human Chorionic Gonadotropin Market, 2016 – 2022 (USD Mn)

List of Tables

TABLE 1 Therapeutics Category
TABLE 2 Market Competition Assessment: Human Chorionic Gonadotropin Products, by Key Players
TABLE 3 Global Human Chorionic Gonadotropin Market, by Treatment, 2014-2022 (USD Mn)
TABLE 4 Global Human Chorionic Gonadotropin Market, by Technology, 2014-2022 (USD Mn)
TABLE 5 Global Human Chorionic Gonadotropin Market, by Geography, 2016 – 2022 (USD Mn)
TABLE 6 Ferring B.V.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 7 Bristol-Myers Squibb Company: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 8 EMD Serono, Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 9 Fresenius Kabi USA, LLC: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 10 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)

Frequently Asked Questions:

What is the size of Human Chorionic Gonadotropin Market?

The market for Human Chorionic Gonadotropin is expected to reach US$ 6.56 Bn in 2028.

What is the Human Chorionic Gonadotropin Market CAGR?

The Human Chorionic Gonadotropin market is expected to see significant CAGR growth over the coming years, at 15.0%.

What is the Forecast period considered for Human Chorionic Gonadotropin Market?

The report is forecasted from 2019-2027.

What is the base year considered for Human Chorionic Gonadotropin Market?

The base year of this report is 2021.

Who are the major players in this market?

Capgemini S.A., EMC Corporation, Hitachi, Ltd., Hewlett-Packard, IBM Corporation, Newgen Software, Inc., Cisco Systems, Inc., SAP SE, SAS Institute, Tata Consultancy Services Ltd. are some of the major players in the global market.

Healthcare

Postoperative Pain Medication Market

Published Date: Oct 2023

Category: Healthcare

Report ID: 62141

Report Format: PDF

No of Pages: 255

HealthCare

Microplate Systems Market

Published Date: Oct. 2023
Category: Medical Devices
Report ID: 62142
Report Format: PDF
No of Pages: 228

Healthcare

Solid Organ Transplant Immunosuppressants Market

Published Date: Oct 2023

Category: Healthcare

Report ID: 62140

Report Format: PDF

No of Pages: 255

 

Healthcare

3D Cell Culture Market

Published Date: Oct 2023
Category: Healthcare
Report ID: 58421
Report Format: PDF
No of Pages: 233

health

Oral Care Market

Published Date: Oct 2023
Category: Healthcare
Report ID: 58117
Report Format: PDF
No of Pages: 190

Healthcare

Healthcare Mobility Solutions Market

Published Date: Oct. 2023
Category: Technology & Media
Report ID: 57752
Report Format: PDF
No of Pages: 236

Healthcare

Autologous Cell Therapy Market

Published Date: Oct 2023
Category: Healthcare
Report ID: 62137
Report Format: PDF
No of Pages: 240

Healthcare

High Grade Neuroendocrine Neoplasms Market

Published Date: Oct. 2023
Category: Healthcare
Report ID: 62130
Report Format: PDF
No of Pages: 222

Healthcare

ELISA Testing Market

Published Date: Oct. 2023
Category: Medical Devices
Report ID: 62139
Report Format: PDF
No of Pages: 247

Healthcare

Orthopedic Implants Market

Published Date: Oct 2023
Category: Healthcare
Report ID: 62136
Report Format: PDF
No of Pages: 231

Healthcare

Hydatid Disease Treatment Market

Published Date: Oct 2023

Category: Healthcare

Report ID: 62135

Report Format: PDF

No of Pages: 231

Healthcare

Clinical Trial Supplies Market

Published Date: Sept 2023
Category: Healthcare
Report ID: 62133
Report Format: PDF
No of Pages: 222

Download Sample Report


Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN
WhatsApp Now